C3T-32621-52609
2 vaccinations
5 coded responses
20 check-ins
5 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 681 / NE
- Registered
- 2021-01-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-16
Dose 1 — Moderna
-
2021-01-17
Registered in v-safe
-
2021-01-17
Survey response — days 1–6 daily, dose 1MedDRA: Urinary tract infection — Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Systemic reaction (other): Woke with UTI 24 hours after vaccination. · Healthcare visit (other): UTI confirmed at Urgent Care Put on MacrobidMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-17
Report sent to call center — days 1–6 daily, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache · Be unable to workAdult check-in
- 2021-01-18
- 2021-01-30
- 2021-02-06
-
2021-02-13
Dose 2 — Moderna
- 2021-02-13
-
2021-02-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-20
-
2021-02-27
Survey response — day 14, dose 2MedDRA: Injection site erythema, Injection site swelling — Feeling: GoodFree text: Raised red area at injection site.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-06
-
2021-03-13
Survey response — day 28, dose 2MedDRA: Injection site nodule — Feeling: GoodFree text: Raised area at injection site. Not painful just raised. Like a fatty tumor.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-16
- 2021-03-16
- 2021-03-20
-
2021-03-27
Survey response — day 42, dose 2MedDRA: Immediate post-injection reaction, Injection site reaction, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: At injection site persistent immune response per Dermotologist. · Healthcare visit (other): Sent a photo to MD have an appointment for her to see in person.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-27
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-17
- 2021-08-14
- 2022-01-14
-
2022-02-14
Survey response — 12 months, dose 2MedDRA: Cystitis, Dry eye, Fatigue, Muscular weakness, Neuropathy peripheral, Office visit, Vaginal infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Adverse reaction to Booster. Neuropathy, muscle weakness, bladder and vaginal, infection, dry eyes, fatigue. · Healthcare visit (other): Primary care and urologist/Gyn and eye doctorMedDRA releases: 2024-11 · check-in free text available
-
2022-02-14
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-16
- 2022-02-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-16 | Moderna | |
| 2 | 2021-02-13 | Moderna |
Call center
4 call center cases
4 unsuccessful
1 wait over 3 months for a first call
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Woke with UTI 24 hours after vaccination.
Healthcare visit (other): UTI confirmed at Urgent Care Put on Macrobid
Release 4 — day 14, dose 2
Symptoms: Raised red area at injection site.
Release 5 — day 28, dose 2
Symptoms: Raised area at injection site. Not painful just raised. Like a fatty tumor.
Release 6 — day 42, dose 2
Symptoms: At injection site persistent immune response per Dermotologist.
Healthcare visit (other): Sent a photo to MD have an appointment for her to see in person.
Release 11 — 12 months, dose 2
Symptoms: Adverse reaction to Booster. Neuropathy, muscle weakness, bladder and vaginal, infection, dry eyes, fatigue.
Healthcare visit (other): Primary care and urologist/Gyn and eye doctor
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| HCVO | Urinary tract infection | ✓ | ✓ | ✓ |
| SD | Cystitis | · | · | ✓ |
| SD | Dry eye | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Immediate post-injection reaction | ✓ | ✓ | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site nodule | ✓ | ✓ | ✓ |
| SD | Injection site reaction | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Muscular weakness | · | · | ✓ |
| SD | Neuropathy peripheral | · | · | ✓ |
| SD | Vaginal infection | · | · | ✓ |
| SRO | Urinary tract infection | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release